ASX Announcement: Green Whistle receives regulatory and marketing approval in the United Kingdom
28 October 2015
ASX ANNOUNCEMENT
Green Whistle receives regulatory and marketing approval in the United Kingdom
Medical Developments International Limited (ASX:MVP) is delighted to announce that it has received final approval from the Medicines and Healthcare Products Regulatory Agency (MHRA)? to market and sell its inhaled analgesic product, ?Penthrox? indicated for trauma and associated pain, in the United Kingdom.
To read the full announcement click on the following link: ?Penthrox receives regulatory and marketing approval in the UK?